Reid Hoffman and Siddhartha Mukherjee’s Manas AI Launches with $24.6M to Tackle Breast Cancer, Lymphoma, and Prostate Cancer

Manas AI, an AI-driven drug discovery startup co-founded by LinkedIn founder Reid Hoffman and cancer researcher Siddhartha Mukherjee, has launched with $24.6 million in seed funding. The startup aims to utilize artificial intelligence technology to identify drug candidates for treating various cancers, including breast cancer, lymphoma, and prostate cancer. The funding amount is notably lower compared to other AI drug discovery ventures, highlighting the competitive landscape in this sector. The launch reflects a growing trend of leveraging AI in healthcare to expedite the drug discovery process.